[3P-0158] Structural basis for anti-non-alcoholic fatty liver disease and diabetic dyslipidemia drug saroglitazar as a PPAR α/ γ dual agonist

^○Akihiro Honda¹, Chihiro Satta¹, Yui Machida¹, Kie Uchii¹, Kazuki Terasawa¹, Ayane Nemoto¹, Shotaro Kamata¹, Takuji Oyama², Isao Ishii¹ (1.Dept. of Health Chem., Showa Pharm. Univ., 2.Fac. of Life and Environ. sci., Univ. of Yamanashi)

h . Protein(1 . Molecular)